National Health Investors (NYSE:NHI) Stock Rating Lowered by Wells Fargo & Company

Wells Fargo & Company cut shares of National Health Investors (NYSE:NHI) from an overweight rating to an equal weight rating in a research note released on Tuesday, MarketBeat.com reports. They currently have $86.00 price target on the real estate investment trust’s stock, up from their previous price target of $81.00.

Several other research firms also recently weighed in on NHI. StockNews.com upgraded National Health Investors from a hold rating to a buy rating in a report on Thursday, August 8th. Bank of America assumed coverage on shares of National Health Investors in a research note on Tuesday, September 24th. They set a buy rating and a $92.00 price objective for the company. Finally, Truist Financial upped their target price on National Health Investors from $65.00 to $78.00 and gave the company a hold rating in a research report on Friday, August 30th. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of Moderate Buy and a consensus target price of $73.29.

National Health Investors Price Performance

NYSE:NHI opened at $81.34 on Tuesday. The business has a 50 day simple moving average of $79.52 and a 200-day simple moving average of $70.28. National Health Investors has a 1 year low of $48.51 and a 1 year high of $86.13. The firm has a market capitalization of $3.53 billion, a price-to-earnings ratio of 26.73, a PEG ratio of 8.86 and a beta of 1.04. The company has a debt-to-equity ratio of 0.91, a current ratio of 10.27 and a quick ratio of 10.27.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share for the quarter, missing the consensus estimate of $1.10 by ($0.29). National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The business had revenue of $84.97 million during the quarter, compared to analysts’ expectations of $64.95 million. During the same quarter in the previous year, the company posted $1.06 earnings per share. The company’s quarterly revenue was up 9.1% compared to the same quarter last year. Equities analysts forecast that National Health Investors will post 4.55 EPS for the current year.

National Health Investors Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Friday, September 27th will be paid a dividend of $0.90 per share. The ex-dividend date of this dividend is Friday, September 27th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.43%. National Health Investors’s dividend payout ratio is currently 118.03%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. increased its position in National Health Investors by 0.7% during the first quarter. Vanguard Group Inc. now owns 6,189,864 shares of the real estate investment trust’s stock worth $388,909,000 after purchasing an additional 43,520 shares during the last quarter. Lasalle Investment Management Securities LLC increased its holdings in shares of National Health Investors by 8.4% during the 1st quarter. Lasalle Investment Management Securities LLC now owns 508,035 shares of the real estate investment trust’s stock worth $31,920,000 after buying an additional 39,554 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. raised its position in shares of National Health Investors by 16.0% during the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 472,959 shares of the real estate investment trust’s stock valued at $32,034,000 after buying an additional 65,104 shares during the period. Land & Buildings Investment Management LLC lifted its holdings in National Health Investors by 4.6% in the second quarter. Land & Buildings Investment Management LLC now owns 417,834 shares of the real estate investment trust’s stock valued at $28,300,000 after acquiring an additional 18,232 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. grew its position in National Health Investors by 4.6% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 197,863 shares of the real estate investment trust’s stock worth $12,432,000 after acquiring an additional 8,642 shares during the period. 62.51% of the stock is currently owned by institutional investors and hedge funds.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.